
Sign up to save your podcasts
Or
Vestibular Specialists Dr. Danielle Tolman, PT and Dr. Abbie Ross, PT, NCS are joined by Sam Owen and Dr. Didier Depireux, Ph.D to talk about their company Otolith Labs and the device that they have been developing for years to help mitigate dizziness and motion sickness: The OtoBand.
"Otolith’s patented non-invasive head-worn technology uses precisely tuned vibrations to interact with the motion sensors in the inner ear, mitigating the symptoms of vertigo and motion sickness. This novel technology has been validated by several clinical studies, including multiple independent studies at universities and with leading automotive manufacturers." Otolith Labs was recently granted De Novo approval by the FDA which provides a pathway to classify novel medical devices for which general controls alone provide reasonable assurance of safety and effectiveness for the intended use, but for which there is no legally marketed predicate device.
You can learn more about Otolith Labs and the Otoband on their website: https://otolithlabs.com/
If you'd like to see if you qualify for their upcoming studies go to: https://otolithlabs.com/studies/vertigotelehealth/
Follow the link to submit topic or guest requests: https://forms.gle/81vh89WKCX2kx6zg7l
Hosted by Dr. Abbie Ross, PT, NCS and Dr. Danielle Tolman, PT
Where to find us:
www.Vestibular.Today
4.9
5050 ratings
Vestibular Specialists Dr. Danielle Tolman, PT and Dr. Abbie Ross, PT, NCS are joined by Sam Owen and Dr. Didier Depireux, Ph.D to talk about their company Otolith Labs and the device that they have been developing for years to help mitigate dizziness and motion sickness: The OtoBand.
"Otolith’s patented non-invasive head-worn technology uses precisely tuned vibrations to interact with the motion sensors in the inner ear, mitigating the symptoms of vertigo and motion sickness. This novel technology has been validated by several clinical studies, including multiple independent studies at universities and with leading automotive manufacturers." Otolith Labs was recently granted De Novo approval by the FDA which provides a pathway to classify novel medical devices for which general controls alone provide reasonable assurance of safety and effectiveness for the intended use, but for which there is no legally marketed predicate device.
You can learn more about Otolith Labs and the Otoband on their website: https://otolithlabs.com/
If you'd like to see if you qualify for their upcoming studies go to: https://otolithlabs.com/studies/vertigotelehealth/
Follow the link to submit topic or guest requests: https://forms.gle/81vh89WKCX2kx6zg7l
Hosted by Dr. Abbie Ross, PT, NCS and Dr. Danielle Tolman, PT
Where to find us:
www.Vestibular.Today
131 Listeners
12,636 Listeners
7,294 Listeners
8,002 Listeners
26,960 Listeners
253 Listeners
1,861 Listeners
57,425 Listeners
12,953 Listeners
28,589 Listeners
41,407 Listeners
19,406 Listeners
10,658 Listeners
55 Listeners
7,841 Listeners